SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-274508
Filing Date
2022-11-01
Accepted
2022-11-01 07:54:31
Documents
14
Period of Report
2022-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d394510d8k.htm   iXBRL 8-K 24481
2 EX-99.1 d394510dex991.htm EX-99.1 202690
6 GRAPHIC g394510g1101055545481.jpg GRAPHIC 5520
  Complete submission text file 0001193125-22-274508.txt   378719

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgen-20221101.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20221101_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20221101_pre.xml EX-101.PRE 11721
8 EXTRACTED XBRL INSTANCE DOCUMENT d394510d8k_htm.xml XML 3507
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 221348533
SIC: 2836 Biological Products, (No Diagnostic Substances)